{
  "ticker": "ROG",
  "year": 2024,
  "name": "Roche Holding AG",
  "ir_url": "https://www.roche.com/investors/reports/annual-reports",
  "data": {
    "Income Statement": {
      "Sales": "58,739",
      "Cost of sales": "-20,897",
      "Gross profit": "37,842",
      "Marketing and distribution": "-9,802",
      "Research and development": "-13,034",
      "General and administration": "-4,145",
      "Operating profit": "10,861",
      "Financing costs": "-909",
      "Other financial income (expense)": "194",
      "Profit before taxes": "10,146",
      "Income taxes": "-1,857",
      "Net income": "8,289",
      "Attributable to Roche shareholders": "7,648",
      "Attributable to non-controlling interests": "641",
      "Basic EPS (CHF)": "9.04",
      "Diluted EPS (CHF)": "9.01"
    },
    "Balance Sheet": {
      "Total non-current assets": "55,495",
      "Total current assets": "38,616",
      "Total assets": "94,111",
      "Equity attributable to Roche shareholders": "24,510",
      "Non-controlling interests": "1,525",
      "Total equity": "26,035",
      "Total non-current liabilities": "30,160",
      "Total current liabilities": "37,916",
      "Total liabilities": "68,076",
      "Total equity and liabilities": "94,111"
    },
    "Cash Flow Statement": {
      "Cash flows from operating activities": "17,475",
      "Cash flows from investing activities": "-5,204",
      "Cash flows from financing activities": "-11,393",
      "Net effect of currency translation": "-72",
      "Increase (decrease) in cash": "806",
      "Cash at beginning of year": "5,412",
      "Cash at end of year": "6,218",
      "Free cash flow": "13,041"
    }
  },
  "tokens_used": 123478
}